Providing confidence in radioactivity measurements
The Nuclear Metrology Group offers a broad range of products and services that underpin the environmental monitoring, nuclear decommissioning and medical radiation industries, providing absolute confidence in radioactivity measurements.
Our services include the supply of standardised radionuclides for the calibration of customer measurement equipment, calibration of customer-supplied samples, calibration of measurement instruments and Proficiency Test Exercises, ensuring industry-wide consistency and accuracy.
Many of our calibration products and measurement services are accredited by UKAS under the ISO 17025 standard. The accredited capability of those services can be found in the calibration and testing schedules issued by UKAS.
Supporting nuclear decommissioning and environmental monitoring
We provide traceability to international standards of radioactivity measurements and classification of radioactive waste, helping our customers overcome regulatory barriers, and ensuring the safety of the general public.
We can supply a range of over 20 different radionuclides for calibration of various detector systems, such as liquid scintillation counters and sodium iodide gamma-detectors. Our range of radionuclides include solid, liquid and gas forms.
Find out about our research for the environment and decommissioning sectors
Supporting nuclear medicine
We provide radiopharmaceutical and nuclear medicine customers with high purity, standardised activity radioisotopes and calibration of customer-supplied samples traceable to NPL primary standards.
Our UKAS-accredited services increases the safety of radiopharmaceuticals and nuclear medicine administered to patients, improves drug development and ensures regulatory requirements are met.
We offer a range of services including the supply of calibration sources or testing of the secondary standard radionuclide calibrator known as the Fidelis to support nuclear medicine departments in hospitals, as well as providing support for clinical trials of new medical isotopes.
Find out more about NPL's Nuclear medicine research
Contact us